Ticker Details
Mineralys Therapeutics, Inc.
IPO Date:	February 10, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.21B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 2.89%
Avg Daily Range (30 D):	$0.81 | 2.63%
Avg Daily Range (90 D):	$0.92 | 2.50%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.98M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	794
Avg Institutional Trade:	$2.42M
Avg Institutional Trade (30 D):	$2.38M
Avg Institutional Trade (90 D):	$2.68M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.16M
Avg Closing Trade (30 D):	$4.28M
Avg Closing Trade (90 D):	$6.24M
Avg Closing Volume:	161.41K

News

Nov 7, 2025 @ 11:10 PM Data for Lorundrostat in Chronic Kidney Disease an... Source: Mineralys Therapeutics

Sep 7, 2025 @ 12:23 PM These 2 Healthcare Stocks More Than Doubled Recent... Source: Cory Renauer

Sep 5, 2025 @ 1:00 PM Mineralys Therapeutics Presents Subgroup Analyses ... Source: Mineralys Therapeutics

Sep 3, 2025 @ 1:33 AM Mineralys Therapeutics Announces Pricing of Upsize... Source: Mineralys Therapeutics

May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.52	$-.66
Diluted EPS		$-.52	$-.66
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-36.93M	$-43.27M
Operating Income / Loss		$-41.13M	$-46.75M
Cost of Revenue
Net Cash Flow		$115.81M	$-63.22M
PE Ratio